Latest News
Featured News
Issue of share options
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™
Update on COVIDITY Phase 1 clinical trial in South Africa
Interim Results for the 6 months ended 31 October 2021
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.